To obtain a deeper understanding of poor responses to COVID-19 vaccination in patients
with lymphoma, we assessed blocking antibodies, total anti-spike IgG, and spike-specific …

Ibrutinib and idelalisib are kinase inhibitors that have revolutionized the treatment of chronic
lymphocytic leukemia (CLL). Capable of inducing durable remissions, these agents also …

Immunodeficiency is a hallmark of chronic lymphocytic leukemia (CLL) and the cause of
much morbidity and mortality. As modern treatments increasingly provide long-term survival …

The anti-spike T-cell and antibody responses to SARS-CoV-2 mRNA vaccines in patients
with B-cell malignancies were examined in a real-world setting. A next-generation …

The B-cell architecture of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is
complex since it is composed of malignant lymphocyte-predominant cells along with a rich B …

Post-coronavirus disease 2019 (post-COVID-19) condition, previously referred to as long
COVID, includes a post-acute syndrome defined by the presence of non-specific symptoms …

The classification of B cell lymphomas—mainly based on light microscopy evaluation by a
pathologist—requires many years of training. Since the B cell receptor (BCR) of the …

Clonal bone marrow (BM) B-cell populations are a common finding in patients with
suspected primary central nervous system lymphoma (PCNSL). To assess their clinical …

In myelodysplastic syndromes with a partial deletion of the long arm of chromosome 5, del
(5q), lenalidomide is believed to reverse anergic T-cell immunity in the bone marrow …

Jill M. Johnsen c, d, e, fa university of Washington, Seattle, Wa, uSa; b Fred hutch Cancer
Center, university of Washington, Seattle, Wa, uSa; c Division of hematology and oncology …